Puente Students' Responses to Irma Herrera's Play
- The Puente Project
- Jan 13, 2022
- 1 min read
On November 30, 2021, we had the opportunity to have Irma Herrera, writer and performer of Why Would I Mispronounce My Own Name? present for a Q&A session with our students. Students were able to stream her play through Latino Theater Co and learned the importance of sharing their names.
Why Would I Mispronounce My Own Name? is one woman’s journey from a small segregated South Texas town to California's multicultural mecca. What part of Irma’s identity is she asked to give up for the sake of fitting in and getting along? How can a simple introduction turn into a potential battle to be heard and seen? Weaving history and comedic insights into stories about names, this solo performer invites us to consider how open and welcoming we really are.
Robyn Orozco, Centennial High School Puente Teacher, sent her class's letters for Ms. Herrera after the event. See a handful of student responses to her play and her response here!
The PV market is expanding through increased diagnostic rates and therapeutic innovation. Leading companies like PharmaEssentia, Incyte, and Protagonist Therapeutics are developing novel JAK inhibitors and targeted treatments that improve hematocrit control and reduce symptom burden. Advancements in molecular testing and treatment guidelines are enhancing personalized care approaches for this chronic myeloproliferative neoplasm.
View Market Insights:https://www.delveinsight.com/infographics/polycythemia-vera-market?utm_source=infographics&utm_medium=promotion&utm_campaign=kkpr
The NSCLC market is expanding due to rising global prevalence and advancements in targeted treatments. Key players like Merck, Roche, and AstraZeneca are driving progress with novel immunotherapies and precision medicines that enhance survival rates. Emerging biomarkers and combination therapies are further optimizing treatment strategies for improved patient outcomes.
View Full Report:https://www.delveinsight.com/infographics/non-small-cell-lung-cancer-market?utm_source=infographics&utm_medium=promotion&utm_campaign=kkpr
Kidney Transplant Rejection Market: Key Developments
Driven by rising transplant rates and innovation in personalized immunosuppression, this market is rapidly evolving. Leading companies like Novartis, Pfizer, and CSL Behring are advancing novel therapeutics and monitoring technologies to enhance graft survival and reduce rejection. Biomarker-driven approaches are transforming post-transplant care management.
Explore Market Insights:https://www.delveinsight.com/infographics/kidney-transplant-rejection-market?utm_source=infographics&utm_medium=promotion&utm_campaign=kkpr
Preeclampsia Treatment Market Outlook
The preeclampsia market is growing due to increasing maternal health awareness and advancements in predictive diagnostics. Key players including Thermo Fisher Scientific, Siemens Healthineers, and Labcorp are developing innovative screening technologies and targeted therapies to address this serious pregnancy complication. Emerging research focuses on placental biomarkers and angiogenic factors to enable early intervention and improved outcomes.
Access Full Report:https://www.delveinsight.com/infographics/preeclampsia-market?utm_source=infographics&utm_medium=promotion&utm_campaign=kkpr
Underactive Bladder Market
Underactive Bladder (UAB) is a condition where the bladder muscles contract weakly or not at all, making it difficult to empty the bladder completely. Symptoms include frequent urination, a weak urine stream, and a sense of incomplete emptying. Causes can include nerve damage, aging, or certain medications.
Download the full infographic to uncover detailed insights: https://www.delveinsight.com/infographics/underactive-bladder-market?utm_source=infographics&utm_medium=promotion&utm_campaign=akpr